| Trial ID: | L0905 |
| Source ID: | NCT02075164
|
| Associated Drug: |
Fructose
|
| Title: |
Unravelling the Pathogenetic Mechanisms of Fructose in Comparison to Glucose Consumption as Multiple Hit in the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease (NAFLD) - an Exploratory Trial
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic Fatty Liver Disease;Non-alcoholic Steatohepatitis
|
| Interventions: |
Dietary Supplement: Fructose;Dietary Supplement: Glucose
|
| Outcome Measures: |
Intrahepatic total fat and ipid composition assessed by Magnetic resonance spectroscopynan
|
| Sponsor/Collaborators: |
Prof. Michael Trauner, MD
|
| Gender: |
All
|
| Age: |
18 Years85 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
56
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
06/02/2014
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT02075164
|
